FROM MOLECULE...TO HUMAN
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
The Service Hospitalier Frédéric Joliot (SHFJ), directed by Vincent Lebon, is a molecular and functional imaging center located on the Orsay hospital site. It ensures a medical service mission and a research and development mission which are mainly in the three following disciplines: oncology, neurology and pharmacology. This research aims to create new imaging tools to improve the diagnosis and evaluation of innovative therapies.
The SHFJ includes a Nuclear Medicine Unit, located in Orsay, which provides the SHFJ medical service mission and three research units: - the BioMaps Joint Research Unit (Multimodal Biomedical Imaging Laboratory Paris-Saclay), under the supervision of CEA, CNRS, Inserm and Université Paris-Saclay, located in Orsay - the Laboratory for Methodological Developments in PET (LDM/TEP), based in Caen - the Transporters in Radiotherapy and Oncology Imaging Unit, located in Nice. The SHFJ also includes a branch of the pharmacy for internal use at the Orsay Hospital for the preparation of radiopharmaceutical drugs and the preparations necessary for biomedical research, including preparation of experimental drugs (Arrêté n° 08-065-91 du 23/05/2008).
SHFJ is also associated with the research team in Clinical Imaging of Neurodegenerative Diseases, and the research team "Child Epilepsy and Cerebral Plasticity".
To carry out their research, SHFJ scientists have access to platforms, integrated into the National Infrastructures in Biology and Health : France Life Imaging (FLI) and NeurATRIS, funded by the french Investments for the Future Program (PIA) : the Experimental Molecular Imaging Research Platform (PRIME), labeled IBiSA, is a preclinical platform dedicated to preclinical and clinical in vivo imaging. The SHFJ also has a 1.5T clinical MRI and a hybrid PET / MRI clinical machine.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.